Potential risk factors for cardiovascular Epidemiology of cardiovascular disease in disease in SLE women
Classical risk factors for cardiovascular disease in SLE appear to be similar to those in the general population: A great misperception is that death from cardiovascular hypercholesterolaemia, diabetes mellitus, smoking, disease is not a major health threat for women. On the contrary, cardiovascular disease, particularly coronary obesity, hypertension, and sedentary lifestyle [1, 2, 17] . heart disease and stroke, is the leading killer of women In a recently reported study, the incidence of myocardial in America. In recent years, it has accounted for nearly infarction and stroke in SLE were significantly increased, half of all deaths in women, more than all forms of even after controlling for expected events based on cancer combined [5] . Significant ethnic differences exist known population-based risk models, suggesting that in cardiovascular disease mortality, which is 31% higher the diagnosis of SLE or its treatment is the strongest in Black than in White females [5] . Cardiovascular known risk factor for cardiovascular disease [18] . disease is also one of the leading causes of disability in Treatment with corticosteroids has been implicated as women [6 ] . Estimates of disability in women survivors a risk factor for atherosclerosis [2, 19, 20] . Whether with coronary heart disease and stroke aged 55-64 yr corticosteroids are directly atherogenic or whether they approximate 36% and 62%, respectively [7] . Previous are causally related to atherosclerosis through enhancereports suggest that women incur more than half the ment of cardiovascular disease risk factors such as costs (estimated to be $274 billion in 1998) of cardiohyperlipidaemia, hyperglycaemia, hypertension, or vascular disease, including lost productivity from obesity remains unclear [21] . In addition, corticosteroids disability [5] .
may be a proxy for severe disease, since patients with Although coronary heart disease is the leading cause severe lupus are more likely to be treated with higher of death among women, coronary events are uncommon doses of corticosteroids for longer periods of time. before the age of 55 yr [8] . Women lag 10-20 yr behind Renal disease, seen in up to 50% of SLE patients, men in the incidence of myocardial infarction, but this may be a risk factor for atherosclerosis. Endothelial cell female advantage diminishes with age [8, 9] . Although damage produced by immune complexes, or other medimost of the classic risk factors for coronary heart disease ators of inflammation, may be responsible for activation in men are also found in women, the magnitude of their of the coagulation system in patients with lupus nepheffects may be different [9, 10] . The most dramatic ritis, resulting in elevated plasma and urine levels of example is diabetes mellitus, which is a stronger risk fibrinogen, a precursor of fibrin. Plasma fibrinogen levels factor for coronary heart disease in women than in men have been reported to be higher in non-lupus postand is the most common cause of premature coronary menopausal women than in both pre-menopausal heart disease in women [11] . Other conditions that women and women taking oestrogen therapy [22] . Elevated fibrinogen levels have been linked to the risk of future heart disease in women [23] . Increased fib-may result in an increased risk of cardiovascular disease formation of a thrombus result in a clinical ischaemic event. in lupus.
Immune complexes. In SLE, immune complexes that fix C1q may be a source of arterial injury initiating Parallels between the pathogenesis of SLE atherogenesis. These complexes bind to C1q receptors and atherosclerosis on the endothelium, triggering an up-regulation of adhesion molecules such as E-selectin and intercellular and Chronic inflammation vascular cell adhesion molecules 1 (ICAM-1 and It is currently believed that atherosclerosis in the general VCAM-1) on the endothelial surface [29] . These population results from a combination of numerous risk C1q fixing immune complexes have also been shown factors. In addition to traditional risk factors, inflamto down-regulate sterol 27-hydroxylase, leading to matory processes are now suspected to be important in increased accumulation of cholesterol in the endothelium atherogenesis [24] . In particular, the inflammatory pro- [30] . Increased amounts of immunoglobulins, complecesses associated with vascular injury are thought to ment components, and C5b-9 complexes have been mediate the development of atherosclerotic lesions.
reported in atherosclerotic lesions [31] [32] [33] . One hypoEpidemiological observations have linked inflammation thesis of atherogenesis is that this intense immune/ with cardiovascular events. C-reactive protein, an acute inflammatory reaction in the plaque may precipitate phase reactant, was shown to predict independently the plaque ulceration, rupture and thrombosis [34] , a risk of future myocardial infarction and stroke in men process that may be accentuated in SLE. with otherwise favourable risk factor profiles [25] , CD40-CD40L interactions. CD40 is a molecule people with multiple risk factors [26 ] , and people with expressed on a variety of cells including B lymphocytes, unstable angina [27] .
macrophages, fibroblasts, and endothelial cells. Inflammatory processes probably contribute to Activated T cells transiently express CD40 ligand atherogenesis in SLE, a disease characterized by chronic (CD40L). In SLE, the interaction between CD40L on inflammation. This author's hypothesis is that the patho-T cells and CD40 on B cells is involved in the production genesis of cardiovascular disease in lupus is multifacof pathogenic autoantibodies [35, 36 ] . Under normal torial, due to an interaction between traditional cardiocircumstances the immune system allows only transient vascular risk factors and inflammation-induced and expression of CD40L. However, patients with SLE antiphospholipid antibody-mediated vascular injury/ express abnormally high levels of CD40L on both thrombosis from the underlying disease. Cortico-T and B cells and the overall number of CD40L-positive steroid treatment and renal disease with resulting hypercells is increased [35] . Furthermore, in lupus nephritis tension may accelerate the atherosclerotic process in patients, CD40 expression is up-regulated on endolupus. Furthermore, the immune dysregulation characthelial cells. teristic of SLE probably plays an important role in
The binding of CD40L to CD40 on endothelial cells atherogenesis.
results in increased expression of VCAM-1, ICAM-1, and E-selectin [37] , adhesion molecules important in Endothelial cell injury facilitating vascular inflammation both in SLE and in atherosclerosis. Furthermore, CD40L induces the release In the 'response to injury' hypothesis of atherosclerosis, several different sources of injury to the endothelium of interleukin-1 by vascular cells, potentially enhancing the inflammatory response [38] . In genetically modified can lead to endothelial cell dysfunction [28] , including immune complexes, viruses, and other toxins such as mice with hypercholesterolaemia that are deficient in apolipoprotein E, ICAM-1 is increased at lesion-prone homocysteine, all of which are also relevant to SLE (Fig. 1) . Such injury results in increased permeability sites [39] . Inhibition of CD40 with blocking antibodies reduced lesion formation in these mice [40] . Thus, and adhesiveness of the endothelium, procoagulative properties, and vasoactive molecule expression [24] . A increased CD40-CD40L interactions may have implications in both the pathogenesis of SLE and the premature prolonged inflammatory response with inadequate down-regulation is characteristic of SLE and may actuatherosclerosis seen in this population. Autoantibodies. Antiphospholipid antibodies provide ally be an important facilitator of atherogenesis in these patients.
additional evidence for immune-mediated atherogenesis.
The most common association of antiphospholipid antiEntrapment and subsequent oxidation of low density lipoprotein (LDL) at the site of endothelial injury is an bodies in SLE is with venous and arterial thromboembolic events, stroke, and recurrent fetal loss [41] . important step in the formation of an atherosclerotic plaque. Endothelial cell adhesion molecules, whose Elevated levels of antibodies to cardiolipin, a phospholipid, have been associated with myocardial infarction expression is up-regulated, bind and recruit monocytes/ macrophages and T lymphocytes to the site of injury.
in non-lupus patients [42, 43] and with macroangiopathy in diabetics [44] . Antibodies to cardiolipin may recogThe inflammatory cells then migrate and localize subendothelially. The macrophages ingest oxidized LDL nize several different antigenic structures; some antibodies bind the lipid component and others bind (oxLDL) and, in conjunction with T cells and smooth muscle cells, form the 'fatty streak', which can then b 2 -glycoprotein I or prothrombin [45, 46 ] . Interestingly, there is evidence that some anticardiolipin antibodies progress to a fibrous plaque. Rupture of the plaque and F. 1. Injury to the vascular endothelium is one of the earliest changes that occurs in atherogenesis. Sources of such injury can be mechanical in nature or arise from immune-mediated processes, viral infection, or toxins such as homocysteine. The resultant endothelial dysfunction leads to altered permeability of the endothelium, increased affinity for leucocytes and platelets, production of vasoactive molecules, and induction of procoagulant properties. In SLE, C1q-fixing immune complexes may be a source of injury to the endothelium, resulting in expression of cell adhesion molecules (ICAM-1, VCAM-1). Interactions between CD40 on endothelial cells and CD40L can stimulate expression of ICAM-1, VCAM-1, and E-selectin. LDL particles are also a major source of injury to the endothelium. When LDL particles are trapped in the arterial wall they become progressively oxidized and can be internalized by macropohages, resulting in the formation of foam cells. Antibodies to oxLDL may actually facilitate foam cell formation. The inflammatory response also stimulates the migration and proliferation of smooth muscle cells that together with T cells and foam cells form the fatty streak. Continued cell influx and smooth muscle proliferation leads to formation of the fibrous plaque. As the fibrous plaque grows, it may protrude into the arterial lumen and impede blood flow, or may rupture or fissure resulting in occlusive thrombosis, ultimately leading to the ischaemic event. (Adapted from [28] .) may be directed against cross-reactive epitopes common these oxidative processes result in the generation of a common antigenic epitope recognized by both antibodies with oxLDL. The presence of antibodies binding to oxLDL is considered a marker of atherosclerosis [47] to phospholipid and oxLDL. In support of this theory is the observation that lysophosphatidylcholine (LPC ) and has been reported to be predictive of future myocardial infarction [43, 48] .
is a major factor in the antigenicity of oxLDL [53] and has been found in atherosclerotic plaques [54] . It was Several investigators have demonstrated that antibodies to oxLDL were higher in SLE patients than control recently reported that patients with SLE had elevated levels of antibodies to both oxLDL and LPC [55] . LPC subjects and correlated with anticardiolipin antibody levels [49, 50] . The recognition of oxLDL by anticardiolcan also be generated enzymatically by phospholipase A2 hydrolysis of phosphatidylcholine, a major phosphoipin antibodies may be partially explained by several observations. Anticardiolipin antibodies of the antilipid component of cellular membranes. This is of particular relevance in SLE where elevated levels of b 2 -glycoprotein I type may recognize oxLDL in complex with b 2 -glycoprotein I [51]. Binding of antibodies to phospholipase A2 expression and activity have been documented [56 ] . In this case both oxidation of LDL b 2 -glycoprotein I-oxLDL complexes may increase LDL uptake into macrophages via Fc receptors, promoting and hydrolysis of phospholipid result in a common product of known antigenicity. the formation of the fatty streak ( Fig. 1) . Furthermore, some antiphospholipid antibodies have been shown to Apolipoprotein A1 (apo A1), the major protein component of high-density lipoprotein (HDL) that acts as be directed against oxidized phospholipids [52] .
The significance of these related observations is not an acceptor of cholesterol from peripheral blood monocytes, is important in the prevention of atherosclerosis completely understood, but one could speculate that [57] . A high prevalence of antibodies to apo A1 has From an epidemiological standpoint, the relationship between these immunological and inflammatory markers also been documented in the sera of patients with SLE [58] . It is possible that antibodies to apo A1 may impede and disease can be examined, but more sensitive methods of defining cardiovascular disease will be required. the uptake of cholesterol into HDL, although this remains to be determined.
Relying on clinical events alone often results in an underestimation of the true prevalence of vascular disInfectious agents. A role for infectious agents has been proposed in the pathogenesis of atherosclerosis [59, 60] .
ease since atherosclerosis may be present for many years before a clinical event occurs. Furthermore, epidemiolIn the 'response to injury' model, infectious agents may serve as a cause of vascular injury or may potentiate ogical studies relying on clinical events as outcomes are difficult since the absolute number of cardiovascular injury by stimulating an inflammatory response. Two organisms currently considered likely candidates in events in SLE is very low. With the advent of sensitive non-invasive screening techniques, such as B-mode ultraatherogenesis are Chlamydia pneumoniae and cytomegalovirus (CMV ). Many studies have documented a serosound and electron beam computed tomography (CT ), we are now better equipped to measure subclinical logical association between C. pneumoniae infection and the development of atherosclerosis [61, 62] . High CMV vascular disease and associated risk factors. From a basic science perspective, we should concenantibody levels were reported in patients requiring cardiovascular surgery [63] , and in the Atherosclerosis trate on the common pathways in the pathogenesis of SLE and atherosclerosis. This effort will involve clarifyRisk in Communities (ARIC ) study CMV seropositivity was reported to be correlated with asymptomatic carotid ing the role of CD40-CD40L interactions and antibodies directed against phospholipids and cholesterol-carrying artery wall thickening [64] . Furthermore, pathological and microbiological evidence has confirmed the presence lipoproteins such as LDL and HDL, as well as pursuing common infectious triggers. and viability of C. pneumoniae and CMV in atherosclerotic plaques [65] . In vitro studies demonstrated that When considering strategies for prevention of premature cardiovascular disease in SLE, modifying tradiinfection of endothelial cells with CMV resulted in divergent patterns of E-selectin, ICAM-1, and VCAM-1 tional risk factors will be only a part of the future programmes. It seems likely that the strongest predictors expression [66 ] and promoted endothelial procoagulant properties [67] .
of cardiovascular disease in this population will be immune and inflammatory in nature. I propose that Although the evidence is circumstantial, infectious agents have gained increasing attention as potential better biological therapies for SLE such as anti-CD40 ligand antibodies will have a greater impact on prevencontributors to the development of SLE. They may initiate or flare SLE by disturbing immunoregulation, tion of atherosclerosis than altering traditional risk factors alone. This concept is supported by findings in causing tissue damage leading to the release of autoantigens, or by eliciting a specific immune response by post-cardiac transplant vasculopathy. Accelerated coronary atherosclerosis is the leading cause of mortality molecular mimicry. Of particular interest are the Epstein-Barr virus [68, 69] and herpes zoster [70] .
in cardiac transplant recipients who survive beyond the first year of transplantation [79, 80] . Although the exact Although viral infection has not been examined in association with atherosclerosis in lupus, it is interesting pathogenesis of cardiac allograft vasculopathy is not completely understood, considerable evidence suggests to speculate that viral factors may play a role in the premature atherosclerosis seen in this population.
that it is an immune-mediated disease that is different from the cell-mediated rejection commonly seen postOther sources of endothelial injury. Another source of potential vascular injury in lupus is elevated homocysttransplant [79, 80] . The proliferative disease is limited to the allograft arterial and venous tree, the nature of eine levels. Homocysteine may have both direct and indirect injurious effects on the endothelium [71, 72] . It the allograft vascular involvement is often diffuse, and development of the disease occurs in allografts of animal is prothrombotic, increases collagen production, and decreases the availability of nitric oxide [73] [74] [75] . Both models with some histocompatibility mismatch but not in isografts. Furthermore, there is evidence to suggest the Physicians' Health Study and the Framingham Heart Study reported an association between homocysteine that more aggressive immunosuppressive treatment directed at blocking cellular processes common to the and an increased relative risk of coronary artery disease, stroke, and carotid vascular disease [76, 77] .
immune response and vascular lesion formation may be effective in reducing or preventing cardiac allograft Homocysteine was elevated in one population of lupus patients and was associated with arterial thrombosis vasculopathy [81] . One could hypothesize that treatment directed towards specific immune dysregulation in SLE [78] . The reasons for hyperhomocysteinaemia in SLE are unclear, and may include dietary-and/or treatmentthat does not have the unfavourable side-effect profile of agents such as corticosteroids will be beneficial in related factors.
preventing premature atherosclerosis in this population. In response to Elizabeth Barrett Conner's eloquent Summary discussion in her 1995 Ancel Keys Lecture on 'why women are so superior with regard to coronary heart We must redirect our focus on the aetiology of cardiovascular disease in SLE to include non-traditional risk disease?' [82] , one should be quick to acknowledge that like women with diabetes mellitus, women with SLE factors such as immune and inflammatory mediators. 
